In early January, the FDA sent out a letter to the manufacturers of 6 influenza

January 29, 2026 No Comments

Fedora Pharmaceuticals a biotechnology company focused on combating antibiotic-resistant infections, announced that it is presenting

January 29, 2026 No Comments

In December 2025, the FDA approved two antibiotics for the treatment of uncomplicated urogenital gonorrhea,

January 28, 2026 No Comments

In the final FY2026 spending bill the Appropriations Committees released last week, Congress rejected the House Republicans’

January 28, 2026 No Comments

An international study found that U.S. long COVID patients report far more brain fog and

January 28, 2026 No Comments

In the course of her study looking at antibiotic treatment selection and failure by race

January 27, 2026 No Comments

Last month, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices

January 27, 2026 No Comments

The treatment landscape for infections caused by metallo-β-lactamase (MBL)–producing Gram-negative bacteria has become clearer—but no

January 27, 2026 No Comments

Evidence regarding the association of social determinants of health (SDOH) with treatment failure (TF) in

January 26, 2026 No Comments

ACON Laboratories announced the retail availability of the Flowflex Plus RSV + Flu A/B +

January 26, 2026 No Comments

Schedule an Appointment

Quick Links